We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01246336
First Posted: November 23, 2010
Last Update Posted: October 31, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Technion, Israel Institute of Technology
Information provided by (Responsible Party):
Ilana Schlesinger, Rambam Health Care Campus
November 21, 2010
November 23, 2010
October 31, 2017
August 2009
January 2012   (Final data collection date for primary outcome measure)
Nanosensory detection [ Time Frame: immediate ]
analyze combinations of nanomaterial-based sensors (organically functionalized carbon nanotubes and gold nanoparticles)
Not Provided
Complete list of historical versions of study NCT01246336 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
Exploratory Study to Detect Volatile Biomarkers of Idiopathic Parkinson's Disease and Parkinsonism From Exhaled Breath Using a Nanomedical Artificial Olfactory System.
Parkinson's disease is diagnosed clinically, because biomarkers that may help in diagnosis and differential diagnosis are not yet available. Exhaled breath testing may yield a "breath-print" that can be used to distinguish healthy and diseased states.
Not Provided
Observational
Observational Model: Other
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
Exhaled breath
Probability Sample
Patients diagnosed with Idiopathic Parkinson's disease and Parkinsonism will be included.
  • Parkinson's Disease
  • Parkinsonism
Other: collection of exhaled breath
no intervention
  • Patients with parkinsonism
    Patients suffering from Parkinson's disease or parkinsonism
    Intervention: Other: collection of exhaled breath
  • Healthy controls
    Patients not suffering from Parkinson's disease or any other neurological disorder
    Intervention: Other: collection of exhaled breath
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
41
January 2012
January 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with Parkinsonism

Exclusion Criteria:

  • Severe dementia
Sexes Eligible for Study: All
30 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01246336
RMB09-0196
No
Not Provided
Not Provided
Ilana Schlesinger, Rambam Health Care Campus
Rambam Health Care Campus
Technion, Israel Institute of Technology
Principal Investigator: Ilana Schlesinger, MD Rambam Health Care Campus
Rambam Health Care Campus
October 2017